Immortals review

Immortals lists sermorelin injection from $95 per month equivalent against a $165 regular display, with three months billed upfront each quarter. It also sells NAD⁺, glutathione and bremelanotide, names its chief medical officer and displays a LegitScript seal. On the sermorelin page, its chief medical officer describes weight-management use as experimental and off-label. The practical limits are the quarterly payment, a Medicine no-refunds policy, no public state list and no named pharmacy for a selected order.

Immortals is a longevity telehealth platform founded by Bryan Johnson and Kate Tolo, with Dr. Carl Seger, MD, as its clinical lead, selling compounded semaglutide and tirzepatide in both personalized and microdose forms, brand-name Wegovy and Zepbound, and a peptide and longevity line: sermorelin injections, NAD⁺ as an injection or nasal spray, glutathione as an injection or nasal spray, bremelanotide as an injection or nasal spray, a peptide skin complex, and a set of generics and branded drugs including metformin, acarbose, estradiol, tretinoin and tadalafil. It displays a LegitScript seal, says no membership is required for medicine, though an optional member discount appears without a verified fee, says its prescriptions are HSA and FSA reimbursable, and describes prescriptions as filled by licensed US pharmacies. It also sells biomarker testing panels and Blueprint supplements.

A US-licensed, board-certified physician reviews your intake, typically within 72 hours, and everything after that — the prescription, unlimited follow-up by chat for up to twelve months, video consults where offered — is bundled into the product price without a required membership fee, according to the site; an optional membership discount is displayed without its total cost established. The site says payment follows a clinician prescription decision. The selected plan total and first quarterly debit are not established by the monthly equivalent shown on the public product page. Two structural features are worth understanding before enrolling. Billing is quarterly with a three-month commitment paid up front, for the examined sermorelin and NAD⁺ options, so their monthly display is not a one-month checkout option. And no state list is published: it says only that treatment is available to adults in eligible US states, with some states requiring a synchronous audio or video consultation before approval, so eligibility is confirmed at intake. Labs are not bundled into the prescription price. Its sermorelin page says your doctor will likely recommend monitoring biomarkers, and Immortals sells biomarker panels covering more than 100 markers, but they are an optional separate purchase rather than a required baseline — the gap to note before a growth-hormone-axis peptide. Its pharmacies are described as licensed US facilities but none is named individually.

The rendered sermorelin injection option starts at $95 per month equivalent against a $165 regular display. NAD⁺ injection shows $119 against $175, and the selected nasal option $101 against $140. These are sale/from and regular display figures, not proof that the higher amount is the next renewal price. Glutathione and bremelanotide are also listed by route, but their selected current plan totals were not verified for this review. The examined medicine pages require three months paid quarterly upfront; no one-month purchase follows from a monthly equivalent. The exact first debit, taxes, supply quantity and future renewal price require plan selection. No membership fee is required for medicine according to the site, though an optional member discount appears without a verified fee. Immortals Medicine sales are final under its refund policy, apart from an error-in-filling contact route. Confirm cancellation timing for future quarters before enrolling.

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Immortals displays a LegitScript seal and describes its pharmacies as licensed US facilities without naming them, and compounded sterile products are not FDA-reviewed for purity and potency the way approved drugs are. On the evidence, this is the rare provider whose own copy does most of the work honestly. Its chief medical officer's quote on the sermorelin page states outright that sermorelin has never been tested in a clinical trial and that using it for weight management is experimental and off-label, correctly noting that it works through the same mechanism as tesamorelin — which does have approved human evidence, for HIV-associated lipodystrophy specifically rather than general wellness. That is precisely our reading. Injected and intranasal NAD⁺ have no controlled human outcome trials; the oral precursors NR and NMN are the studied forms and they raise blood NAD⁺, a biomarker rather than a demonstrated benefit. Glutathione by injection or nasal spray has essentially no controlled human outcome evidence. Bremelanotide is the outlier with genuine randomized human data, for hypoactive sexual desire disorder specifically, and the platform cites the published trials by name — the effect there is real but modest. Individual results vary.